首页 > 市场调查报告书 > 材料/化学品

硫酸软骨素市场规模、份额和成长分析（按来源、形态、应用和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1907583

硫酸软骨素市场规模、份额和成长分析（按来源、形态、应用和地区划分）－2026-2033年产业预测

Chondroitin Sulfate Market Size, Share, and Growth Analysis, By Source (Bovine, Swine), By Form (Powder, Tablet), By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，硫酸软骨素市场价值将达到 12.8 亿美元，到 2025 年将成长至 13.3 亿美元，到 2033 年将成长至 18.1 亿美元，在预测期（2026-2033 年）内复合年增长率为 3.9%。

由于骨关节炎发病率的上升和膳食补充剂的日益普及，市场对硫酸软骨素的需求正在增长。这种化合物在治疗尿道感染、白内障和骨关节炎等疾病方面发挥重要作用，同时也有助于血糖值控制、抑制肿瘤和改善肝功能。它存在于软骨、关节和结缔组织中，有助于改善关节功能，使其成为一种极具吸引力的补充剂。肉类消费量的快速成长和宠物产业的蓬勃发展进一步推动了市场成长，因为硫酸软骨素是从动物的珍贵部位提取的。此外，其用途广泛，涵盖医学、营养和兽医学领域，巩固了其作为肌肉骨骼健康和各种疾病关键解决方案的市场潜力，特别适合寻求天然疗法的消费者。

硫酸软骨素市场驱动因素

关节疾病，尤其是骨关节炎的日益普遍，与世界人口老化密切相关。随着越来越多的人患有与老龄化相关的疾病，对有效治疗方法的需求也日益增长，而硫酸软骨素正逐渐成为热门选择。硫酸软骨素因其缓解疼痛、减轻发炎和改善关节功能的功效而闻名，在医学界备受关注。这种对改善关节问题日益增长的需求，正显着推动着硫酸软骨素市场的发展。因此，对提高老年族群生活品质的关注，进一步凸显了该化合物在关节健康治疗方案中的重要作用。

限制硫酸软骨素市场的因素

由于各国监管标准和要求各不相同，硫酸软骨素市场面临许多挑战。遵守这些法规既复杂又繁琐，也为新参与企业设置了重大障碍。因此，合规流程可能会阻碍企业有效进入市场。此外，由于现有企业必须投入大量资源来遵守这些准则，监管方面的挑战也会影响硫酸软骨素市场的整体成长，限制创新和扩张的空间。这种复杂的市场环境限制了市场的潜在发展。

硫酸软骨素市场趋势

受消费者对天然和有机成分日益增长的需求驱动，硫酸软骨素市场正经历一场意义深远的变革时期。随着注重健康的消费者越来越倾向于选择能够反映整体生活方式的膳食补充剂，源自天然来源（包括牛、猪源和海洋来源）的硫酸软骨素的需求也随之增长。这一趋势迫使生产商不断创新并丰富产品线，以满足消费者对透明度、永续性和品质的偏好。为了保持竞争力，各公司正加大研发投入，以提供能够满足这些不断变化的需求的配方，从而塑造硫酸软骨素市场的未来。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

TSI Group Co., LTD（China）
Qingdao Wan Toulmin Biological Sources Co., Ltd.（China）
Hebei Sanxin Industry Group Co., Ltd.（China）
Bioiberica SAU（Spain）
Sigma-Aldrich, Inc.（Merck KGaA, Germany）
ZPD A/S（Denmark）
Sino Siam Biotechnique Company Ltd.（Thailand）
BRF SA（Brazil）
Bio-gen Extracts Pvt. Ltd.（India）
Seikagaku Corporation（Japan）
Yantai Dongcheng Pharmaceutical Group Co., Ltd.（China）
Shandong Haiyu Biological Co., Ltd.（China）
Jiaxing Hengjie Biopharmaceutical Co., Ltd.（China）
Lianyungang Zhonghai Biological Technology Co., Ltd.（China）
Yantai Ruikangda Biochemical Products Co., Ltd.（China）
Shandong Topscience Biotech Co., Ltd.（China）
Titan Biotech Ltd.（India）
Fido Pharma Pvt. Ltd.（India）
Velnex Medicare（India）
TSI Group Ltd.（United States）

结论与建议

简介目录

Product Code: SQMIG15E2266

Chondroitin Sulfate Market size was valued at USD 1.28 Billion in 2024 and is poised to grow from USD 1.33 Billion in 2025 to USD 1.81 Billion by 2033, growing at a CAGR of 3.9% during the forecast period (2026-2033).

Chondroitin sulfate is experiencing heightened demand driven by the rising prevalence of osteoarthritis and the increasing popularity of nutraceutical products. This compound serves a vital role in treating conditions such as urinary tract infections, cataracts, and osteoarthritis, while also assisting in blood sugar management, tumor suppression, and liver function improvement. Its presence in cartilage, joints, and connective tissues contributes to enhanced joint performance, making it an attractive supplement. The surge in meat consumption and the burgeoning pet industry drive the market further, as chondroitin sulfate is derived from valuable animal parts. Moreover, its versatility spans medical, nutritional, and veterinary applications, solidifying its market potential as a key solution for musculoskeletal health and various ailments in consumers seeking natural therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Chondroitin Sulfate market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Chondroitin Sulfate Market Segments Analysis

Global Chondroitin Sulfate Market is segmented by Source, Form, Application and region. Based on Source, the market is segmented into Bovine, Swine, Poultry, Shark and Others. Based on Form, the market is segmented into Powder, Tablet and Others. Based on Application, the market is segmented into Pharmaceuticals andNutraceuticals, Animal Feed, Personal Care and Cosmetics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Chondroitin Sulfate Market

The rising prevalence of joint disorders, particularly osteoarthritis, is closely linked to the aging global population. As more individuals experience age-related ailments, the demand for effective treatments increases, with chondroitin sulfate emerging as a popular option. Known for its ability to alleviate pain, reduce inflammation, and enhance joint functionality, chondroitin sulfate has garnered attention in the healthcare sector. This growing need for remedying joint issues significantly propels the chondroitin sulfate market forward. Consequently, the emphasis on improving quality of life for older adults further underscores the vital role this compound plays in therapeutic solutions for joint health.

Restraints in the Chondroitin Sulfate Market

The chondroitin sulfate market faces numerous challenges due to the regulatory standards and requirements established by various countries. Navigating these regulations can be intricate and labor-intensive, posing significant obstacles for new entrants. As a result, the compliance process may hinder their ability to effectively penetrate the market. Furthermore, these regulatory challenges can also affect the overall growth of the chondroitin sulfate market, as existing companies may need to allocate substantial resources to ensure adherence to these guidelines, thereby limiting their capacity to innovate and expand. This complex landscape creates a restriction on the potential advancements within the market.

Market Trends of the Chondroitin Sulfate Market

The Chondroitin Sulfate market is experiencing a significant shift driven by a rising consumer inclination towards natural and organic ingredients. As health-conscious individuals increasingly seek supplements that reflect their holistic lifestyle choices, there is a growing demand for chondroitin sulfate sourced from natural origins like bovine, porcine, and marine sources. This trend compels manufacturers to innovate and diversify their product offerings to align with consumer preferences for transparency, sustainability, and quality. To stay competitive, companies are investing in research and development to provide formulations that meet these evolving demands, ultimately shaping the future landscape of the Chondroitin Sulfate market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis
Patent Analysis

Global Chondroitin Sulfate Market Size by Source & CAGR (2026-2033)

Market Overview
Bovine
Swine
Poultry
Shark
Others

Global Chondroitin Sulfate Market Size by Form & CAGR (2026-2033)

Market Overview
Powder
Tablet
Others

Global Chondroitin Sulfate Market Size by Application & CAGR (2026-2033)

Market Overview
Pharmaceuticals and Nutraceuticals
Animal Feed
Personal Care and Cosmetics
Others

Global Chondroitin Sulfate Market Size & CAGR (2026-2033)

North America (Source, Form, Application)
- US
- Canada
Europe (Source, Form, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Source, Form, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Source, Form, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Source, Form, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

TSI Group Co., LTD (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qingdao Wan Toulmin Biological Sources Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hebei Sanxin Industry Group Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioiberica S.A.U. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich, Inc. (Merck KGaA, Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZPD A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sino Siam Biotechnique Company Ltd. (Thailand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BRF S.A. (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-gen Extracts Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seikagaku Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Yantai Dongcheng Pharmaceutical Group Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shandong Haiyu Biological Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiaxing Hengjie Biopharmaceutical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lianyungang Zhonghai Biological Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Yantai Ruikangda Biochemical Products Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shandong Topscience Biotech Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Titan Biotech Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fido Pharma Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Velnex Medicare (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TSI Group Ltd. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments